人类呼吸道合胞病毒(hRSV)是一种包膜病毒,尤其会引起婴幼儿和高龄老人的严重呼吸道感染,它与流感病毒同为RNA病毒,G蛋白和F蛋白是RSV膜表面两个重要的糖蛋白因此,许多抗病毒药物的靶点是针对这两种蛋白进行开发的。 很可惜的是,虽然RSV是一个非常重要的呼吸道病毒,但是在儿童呼吸道合胞病毒感染诊断、治疗和预防专家...
近日,万孚生物美国全资子公司Wondfo USA Co.,Ltd(以下简称“美国子公司”)收到美国食品药品监督管理局(FDA)通知,美国子公司的新型冠状病毒、甲型流感病毒及乙型流感病毒三联检测试剂盒WELLlife™ COVID-19/Influenza A&B Test获得FDA的应急使用授权(EUA24000...
流行性感冒(influenza,流感)是由流感病毒引起的一种急性呼吸道传染病,具有流行面广、传染性强以及发病率高等特点,其波及范围之广、造成的经济损失之大位于传染性疾病之首。 流感病毒属于正粘病毒科,为RNA病毒。根据核蛋白和基质蛋白分为甲、乙、丙、丁四型,其中人类中最常见的是甲型和乙型。甲型和乙型流感潜伏期一...
Table 1. Synthesis of α-aminophosphonates—optimization 1. Under optimized conditions (Table 1, entry 5), the six imines 2a–f bearing either electron-donating or electron-withdrawing substituents on the phenyl ring, were put in the presence of diethyl phosphite to generate the corresponding 1...
(B) general structure (I) of the library of 1,4,4-trisubstituted piperidine compounds that we synthesized in the present work to explore the SAR for anti-CoV activity. Over the course of the above study focused on influenza virus, the 1,4,4-trisubstituted piperidines were also evaluated ...
Influence of influenza A virus in COVID-19 patients: A retrospective cohort study 来自钛学术 作者Y Cheng,J Ma,H Wang,X Wang,X Liu摘要 Background and objective: Coronavirus disease (COVID-19) is current...
证券日报网讯 4月22日晚间,万孚生物发布公告称,公司美国全资子公司Wondfo USA Co.,Ltd(简称“美国子公司”)近日收到U.S.Food&Drug Administration(美国食品药品监督管理局,以下简称“FDA”)通知,美国子公司的新型冠状病毒、甲型流感病毒及乙型流感病毒三联检测试剂盒WELLlifeCOVID-19/Influenza A&BTest获得FDA的应急...
and A549 infected with either SARS-CoV2, Influenza A virus (IAV), Respiratory Syncytial virus (RSV), or human parainfluenza virus type 3 (HPIV3) against mock treated cells. Expression andpvalues were calculated with DESeq2 using Wald test statistic and Benjamini-Hochberg correction for multiple...
Concomitant administration of COVID-19 and influenza vaccines could reduce burden on health-care systems. We aimed to assess the safety of concomitant administration of ChAdOx1 or BNT162b2 plus an age-appropriate influenza vaccine. Methods In this multicentre, randomised, controlled, phase 4 trial,...
Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination in the US. JAMA Netw Open. 2022;5(7):e2222241. doi:10.1001/jamanetworkopen.2022.22241 ArticlePubMedGoogle ScholarCrossref 20. Moro PL, Zhang B, Ennulat C, et al. Safety of co-...